Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoonha Choi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
BMC Pulmonary Medicine|November 19, 2017
Analytical performance of Envisia: a genomic classifier for usual interstitial pneumoniaYoonha Choi, Jiayi Lu, Zhanzhi Hu, et al.
Plos Genetics|March 8, 2011
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOEEllen M Wijsman, Nathan D Pankratz, Yoonha Choi, et al.
Annals of the American Thoracic Society|October 24, 2017
Reply: Improving Care for Patients with Interstitial Lung Disease, Using Machine Learning, Requires Transparency and ReproducibilityGiulia C Kennedy, Neil M Barth, P Sean Walsh, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
Nature Communications|April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Nature Communications|October 23, 2023
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
The Lancet. Respiratory Medicine|May 25, 2015
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional dataSu Yeon Kim, James Diggans, Dan Pankratz, et al.
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Nature|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMC Pulmonary Medicine|November 19, 2017
Analytical performance of Envisia: a genomic classifier for usual interstitial pneumoniaYoonha Choi, Jiayi Lu, Zhanzhi Hu, et al.
Plos Genetics|March 8, 2011
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOEEllen M Wijsman, Nathan D Pankratz, Yoonha Choi, et al.
Annals of the American Thoracic Society|October 24, 2017
Reply: Improving Care for Patients with Interstitial Lung Disease, Using Machine Learning, Requires Transparency and ReproducibilityGiulia C Kennedy, Neil M Barth, P Sean Walsh, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
Nature Communications|April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Nature Communications|October 23, 2023
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
The Lancet. Respiratory Medicine|May 25, 2015
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional dataSu Yeon Kim, James Diggans, Dan Pankratz, et al.
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Nature|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Pageof 4